Home / health news / Bristol-Myers Squibb Company (BMY) Stake Reduced by Jacobus Wealth Management Inc. quoting : Sports Perspectives
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

Bristol-Myers Squibb Company (BMY) Stake Reduced by Jacobus Wealth Management Inc. quoting : Sports Perspectives

as mentioned in Receive News & Ratings for Bristol-Myers Squibb Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bristol-Myers Squibb Company and related companies with MarketBeat.com’s FREE daily email newsletter.
Jacobus Wealth Management Inc.’s holdings in Bristol-Myers Squibb Company were worth $2,671,000 as of its most recent filing with the SEC.
COPYRIGHT VIOLATION NOTICE: “Bristol-Myers Squibb Company (BMY) Stake Reduced by Jacobus Wealth Management Inc.” was first published by Sports Perspectives and is the property of of Sports Perspectives.
About Bristol-Myers Squibb CompanyBristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.
Jacobus Wealth Management Inc. decreased its stake in Bristol-Myers Squibb Company (NYSE:BMY) by 4.3% during the third quarter, according to its most recent 13F filing with the SEC.

Bristol-Myers Squibb Company (BMY) Stake Reduced by Jacobus Wealth Management Inc.

as mentioned in Receive News & Ratings for Bristol-Myers Squibb Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bristol-Myers Squibb Company and related companies with MarketBeat.com’s FREE daily email newsletter.
About Bristol-Myers Squibb CompanyBristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.
Jefferies Group LLC reiterated their buy rating on shares of Bristol-Myers Squibb Company (NYSE:BMY) in a research report released on Tuesday morning.
COPYRIGHT VIOLATION WARNING: “Bristol-Myers Squibb Company (BMY) Receives Buy Rating from Jefferies Group LLC” was posted by Sports Perspectives and is owned by of Sports Perspectives.
Barclays PLC restated an equal weight rating on shares of Bristol-Myers Squibb Company in a report on Wednesday, October 12th.

as mentioned in

Van Hulzen Asset Management LLC Raises Position in Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company Company ProfileBristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.
Van Hulzen Asset Management LLC’s holdings in Bristol-Myers Squibb Company were worth $1,911,000 as of its most recent filing with the SEC.
TRADEMARK VIOLATION WARNING: “Van Hulzen Asset Management LLC Raises Position in Bristol-Myers Squibb Company (BMY)” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem.
Robeco Institutional Asset Management B.V. raised its stake in shares of Bristol-Myers Squibb Company by 49.5% in the second quarter.
Receive News & Stock Ratings for Bristol-Myers Squibb Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bristol-Myers Squibb Company and related stocks with our FREE daily email newsletter.

about the details read more from here

This content may collect you by Luaren Colin

To follow all the new news about health

Check Also

picture.jpg

2 missing girls found safe, mother detained according to : KCRA

as informed in Two missing girls were found safe after being taken by their biological …